silodosin
| SMILES | OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N |
| InChIKey | PNCPYILNMDWPEY-QGZVFWFLSA-N |
Chemical properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 3 |
| Rotatable bonds | 13 |
| Molecular weight (Da) | 495.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 9.4 | 9.9 | 10.4 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 6.5 | 7.1 | 7.7 | Guide to Pharmacology |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 6.9 | 7.8 | 8.7 | Guide to Pharmacology |
| 5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 7.04 | 7.04 | 7.04 | ChEMBL |
| 5-HT1B | 5HT1B | Human | 5-Hydroxytryptamine | A | pKi | 6.43 | 6.43 | 6.43 | ChEMBL |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 6.71 | 7.21 | 7.7 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 7.33 | 8.02 | 8.7 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.11 | 6.11 | 6.11 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.44 | 6.44 | 6.44 | ChEMBL |
| 5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 6.32 | 6.32 | 6.32 | ChEMBL |
| H1 | HRH1 | Human | Histamine | A | pKi | 5.45 | 5.45 | 5.45 | ChEMBL |
| D4 | DRD4 | Human | Dopamine | A | pKi | 5.8 | 5.8 | 5.8 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 7.52 | 9.45 | 10.44 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 6.17 | 6.17 | 6.17 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 5.68 | 5.68 | 5.68 | ChEMBL |
| β2 | ADRB2 | Human | Adrenoceptors | A | pKi | 7.48 | 7.48 | 7.48 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 7.33 | 7.33 | 7.33 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 7.14 | 7.14 | 7.14 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pKi | 6.0 | 6.0 | 6.0 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 7.98 | 7.98 | 7.98 | Drug Central |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 8.11 | 8.11 | 8.11 | Drug Central |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.06 | 8.06 | 8.06 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1B | ADA1B | Rat | Adrenoceptors | A | pIC50 | 7.04 | 7.04 | 7.04 | ChEMBL |
| α1B | ADA1B | Human | Adrenoceptors | A | pIC50 | 6.27 | 6.61 | 6.94 | ChEMBL |
| α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 9.1 | 9.1 | 9.1 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pIC50 | 7.56 | 7.88 | 8.2 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pIC50 | 8.72 | 8.73 | 8.74 | ChEMBL |
| β2 | ADRB2 | Human | Adrenoceptors | A | pIC50 | 6.67 | 6.67 | 6.67 | ChEMBL |
| α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 8.04 | 8.04 | 8.04 | Drug Central |